Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEACHI-02: AdCh3NSmut1 and MVA-NSmut in HIV+ Adults
NCT02568332Phase 1Completed
- Sponsor
- University of Oxford
- Start
- Jul 2015
- Primary completion
- Jan 2017
- Modality
- Prophylactic Vaccines, Gene Editing, Gene Silencing
- Countries
- 2
01
Overview
Phase 1, open-label, single-arm trial of AdCh3NSmut and MVA-NSmut in hepatitis C (HCV), sponsored by University of Oxford. Primary endpoint: Proportion of participants who develop a grade 3 or 4 local or systemic reaction. Started Jul 2015; status: completed.
02
Drugs
AdCh3NSmutMVA-NSmut
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02568332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02568332.